Intissar Anan

1.2k total citations
53 papers, 718 citations indexed

About

Intissar Anan is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Intissar Anan has authored 53 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 11 papers in Nephrology and 9 papers in Epidemiology. Recurrent topics in Intissar Anan's work include Amyloidosis: Diagnosis, Treatment, Outcomes (44 papers), Alzheimer's disease research and treatments (9 papers) and Parathyroid Disorders and Treatments (9 papers). Intissar Anan is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (44 papers), Alzheimer's disease research and treatments (9 papers) and Parathyroid Disorders and Treatments (9 papers). Intissar Anan collaborates with scholars based in Sweden, Japan and Egypt. Intissar Anan's co-authors include Ole B. Suhr, Jonas Wixner, Yukio Ando, Pontus Karling, Magdy El‐Salhy, Nils Nyhlin, Björn Pilebro, Joel N. Buxbaum, Onur N. Karayal and Per Westermark and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Intissar Anan

48 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Intissar Anan Sweden 18 627 196 124 116 102 53 718
J Turner United Kingdom 12 510 0.8× 75 0.4× 67 0.5× 101 0.9× 53 0.5× 16 797
Ranjan Das South Korea 11 236 0.4× 173 0.9× 64 0.5× 13 0.1× 84 0.8× 20 522
Beiru Zhang China 13 335 0.5× 78 0.4× 172 1.4× 32 0.3× 44 0.4× 27 492
Laëtitia Gorisse France 12 205 0.3× 81 0.4× 70 0.6× 28 0.2× 28 0.3× 21 464
Dmitri Svistounov Norway 12 187 0.3× 47 0.2× 111 0.9× 52 0.4× 77 0.8× 19 632
Ferhan Siddiqi Canada 11 280 0.4× 181 0.9× 49 0.4× 28 0.2× 63 0.6× 22 560
Junhui Zhen China 15 333 0.5× 137 0.7× 47 0.4× 21 0.2× 53 0.5× 24 578
Bozena Krolewski United States 12 200 0.3× 145 0.7× 49 0.4× 52 0.4× 58 0.6× 26 468
Boquan Wu China 13 357 0.6× 25 0.1× 50 0.4× 81 0.7× 29 0.3× 23 548
Beilei Zhao China 11 197 0.3× 106 0.5× 53 0.4× 30 0.3× 40 0.4× 20 430

Countries citing papers authored by Intissar Anan

Since Specialization
Citations

This map shows the geographic impact of Intissar Anan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Intissar Anan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Intissar Anan more than expected).

Fields of papers citing papers by Intissar Anan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Intissar Anan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Intissar Anan. The network helps show where Intissar Anan may publish in the future.

Co-authorship network of co-authors of Intissar Anan

This figure shows the co-authorship network connecting the top 25 collaborators of Intissar Anan. A scholar is included among the top collaborators of Intissar Anan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Intissar Anan. Intissar Anan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Backman, Janne T., et al.. (2024). Misfolding of transthyretin in vivo is controlled by the redox environment and macromolecular crowding. Journal of Biological Chemistry. 301(1). 108031–108031. 2 indexed citations
2.
Lindqvist, Per, et al.. (2024). Assessing left atrial dysfunction in cardiac amyloidosis using LA–LV strain slope. PubMed. 2(3). qyae100–qyae100. 3 indexed citations
3.
Eriksson, Robert, et al.. (2023). Enlarged cross-sectional area in peripheral nerves in Swedish patients with hereditary V30M transthyretin amyloidosis. Annals of Medicine. 55(2). 2239269–2239269.
4.
Bäckström, David, Intissar Anan, Jonas Wixner, et al.. (2022). Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors. Frontiers in Neurology. 13. 816636–816636. 9 indexed citations
5.
Westermark, Per, Ole B. Suhr, Intissar Anan, et al.. (2020). Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis. Orphanet Journal of Rare Diseases. 15(1). 278–278. 30 indexed citations
6.
Ragheb, A, et al.. (2019). PCN487 COST OF PROSTATE CANCER AND QUALITY OF LIFE IN EGYPT - A PATIENT PERSPECTIVE STUDY. Value in Health. 22. S531–S532. 1 indexed citations
7.
Suhr, Ole B., Jonas Wixner, Intissar Anan, et al.. (2019). Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families. PLoS ONE. 14(2). e0211983–e0211983. 14 indexed citations
9.
10.
Assaad‐Khalil, Samir H., et al.. (2017). The Financial Burden of Diabetes Mellitus Type 1 And Type 2 In Egypt. Value in Health. 20(9). A477–A477. 4 indexed citations
11.
Anan, Intissar, Bo‐Göran Ericzon, Johanna Pennlert, et al.. (2017). Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients. Transplantation. 102(2). e59–e66. 17 indexed citations
12.
Wixner, Jonas, Torbjörn Sundström, Pontus Karling, Intissar Anan, & Ole B. Suhr. (2015). Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis. BMC Gastroenterology. 15(1). 51–51. 8 indexed citations
13.
Obayashi, Konen, Masayoshi Tasaki, Hirofumi Jono, et al.. (2013). Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine. Clinica Chimica Acta. 419. 127–131. 6 indexed citations
14.
Wixner, Jonas, Pontus Karling, Anders Rydh, et al.. (2012). Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy. Neurogastroenterology & Motility. 24(12). 1111–1111. 21 indexed citations
15.
Matsunaga, Noriko, Intissar Anan, Peter Rosenberg, et al.. (2005). Advanced glycation end product is implicated in amyloid‐related kidney complications. Scandinavian Journal of Clinical and Laboratory Investigation. 65(4). 263–272. 14 indexed citations
16.
Nyhlin, Nils, et al.. (2002). Reduction of free radical activity in amyloid deposits following liver transplantation for familial amyloidotic polyneuropathy. Journal of Internal Medicine. 251(2). 136–141. 9 indexed citations
17.
Ando, Yukio, Intissar Anan, Gösta Holmgren, et al.. (2000). Enhancement of AA-amyloid formation in mice by transthyretin amyloid fragments and polyethylene glycol. Biochimica et Biophysica Acta (BBA) - General Subjects. 1474(3). 331–336. 10 indexed citations
18.
Anan, Intissar, Magdy El‐Salhy, Nils Nyhlin, & Ole B. Suhr. (2000). LIVER TRANSPLANTATION RESTORES ENDOCRINE CELLS IN PATIENTS WITH FAMILIAL AMYLOIDOTIC POLYNEUROPATHY1. Transplantation. 70(5). 794–799. 13 indexed citations
19.
Nyhlin, Nils, Intissar Anan, Magdy El‐Salhy, Yukio Ando, & Ole B. Suhr. (1999). Endocrine cells in the upper gastrointestinal tract in relation to gastrointestinal dysfunction in patients with familial amyloidotic polyneuropathy. Amyloid. 6(3). 192–198. 17 indexed citations
20.
Anan, Intissar, Magdy El‐Salhy, Yukio Ando, et al.. (1999). Colonic enteric nervous system in patients with familial amyloidotic neuropathy. Acta Neuropathologica. 98(1). 48–54. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026